BRAINMED AS

3045 DRAMMEN

Finances

Return on Equity

38,47 %

Current Ratio

1,59

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	3 392 000	3 639 000	5 266 000	3 840 000
Net Income	459 000	20 000	1 197 000	401 000
Total Assets	2 657 000	2 277 000	3 020 000	2 783 000
Total Equity	1 193 000	734 000	2 213 000	1 016 000

Income (NOK)	2022	2021	2020	2019
Revenue	3 392 000	3 639 000	5 266 000	3 840 000
Expenditure	2 803 000	3 622 000	3 613 000	3 425 000
Operating Profit	590 000	18 000	1 653 000	527 000
Financial Income	25 000	18 000	23 000	4 000
Financial Costs	28 000	8 000	109 000	17 000
Financial Balance	−3 000	10 000	−86 000	−13 000
Earnings Before Tax	588 000	27 000	1 566 000	514 000
Tax	129 000	7 000	369 000	113 000
Net Income	459 000	20 000	1 197 000	401 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	325 000	389 000	361 000	894 000
Total Current Assets	2 332 000	1 888 000	2 659 000	1 889 000
Total Assets	2 657 000	2 277 000	3 020 000	2 783 000
Total Retained Equity	1 090 000	631 000	2 111 000	914 000
Total Equity	1 193 000	734 000	2 213 000	1 016 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	1 465 000	1 543 000	807 000	1 767 000
Total Equity and Debt	2 657 000	2 277 000	3 020 000	2 783 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	3 392 000	3 639 000	5 249 000	3 840 000
Other Income	0	0	17 000	0
Revenue	3 392 000	3 639 000	5 266 000	3 840 000
Cost of Goods Sold	1 866 000	2 051 000	2 539 000	2 251 000
Salary Costs	519 000	1 027 000	655 000	786 000
Depreciation	66 000	107 000	68 000	76 000
Impairment	0	0	0	0
Expenditure	2 803 000	3 622 000	3 613 000	3 425 000
Operating Profit	590 000	18 000	1 653 000	527 000
Financial Income	25 000	18 000	23 000	4 000
Financial Costs	28 000	8 000	109 000	17 000
Financial Balance	−3 000	10 000	−86 000	−13 000
Dividends	0	0	0	0
Net Income	459 000	20 000	1 197 000	401 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	14 000	12 000	4 000	34 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	11 000	25 000	40 000	0
Fixtures	144 000	195 000	287 000	171 000
Total Tangible Assets	155 000	221 000	327 000	171 000
Total Fiancial Fixed Assets	156 000	156 000	30 000	689 000
Total Fixed Assets	325 000	389 000	361 000	894 000
Stock	133 000	159 000	533 000	321 000
Total Investments	0	0	0	0
Cash, Bank	2 018 000	1 037 000	1 607 000	1 209 000
Total Current Assets	2 332 000	1 888 000	2 659 000	1 889 000
Total Assets	2 657 000	2 277 000	3 020 000	2 783 000
Total Equity	1 193 000	734 000	2 213 000	1 016 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	32 000	105 000	120 000	182 000
Unpaid Taxes	96 000	242 000	286 000	237 000
Dividends	0	0	0	0
Other Current Debt	1 205 000	1 181 000	61 000	1 236 000
Total Current Debt	1 465 000	1 543 000	807 000	1 767 000
Total Equity and Debt	2 657 000	2 277 000	3 020 000	2 783 000

Financial indicators	2022	2021	2020	2019
Return on Equity	38,47 %	2,72 %	54,09 %	39,47 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	17,39 %	0,49 %	31,39 %	13,72 %
Current Ratio	1,59	1,22	3,29	1,07
Quick Ratio	1,75	1,36	9,7	1,31
Equity Ratio	0,45	0,32	0,73	0,37
Gross Profit Margin	44,99 %	43,64 %	51,79 %	41,38 %